{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T06:40:57Z","timestamp":1768632057068,"version":"3.49.0"},"reference-count":0,"publisher":"Frontline Medical Communications, Inc.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,1]]},"DOI":"10.12788\/cutis.0685","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T15:22:09Z","timestamp":1676042529000},"source":"Crossref","is-referenced-by-count":3,"title":["Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib"],"prefix":"10.12788","volume":"111","author":[{"given":"Ivie","family":"Obeime","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5043","container-title":["Cutis"],"original-title":[],"link":[{"URL":"https:\/\/cdn.mdedge.com\/files\/s3fs-public\/CT111001010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T15:22:09Z","timestamp":1676042529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdedge.com\/dermatology\/article\/260423\/hair-nails\/alopecia-areata-skin-color-patients-new-considerations-sparked"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,1]]},"references-count":0,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,2,9]]},"published-print":{"date-parts":[[2023,1,1]]}},"URL":"https:\/\/doi.org\/10.12788\/cutis.0685","relation":{},"subject":[],"published":{"date-parts":[[2023,1,1]]}}}